Jessica Rose Wilson, MD, MS
Adjunct Assistant Professor of Medicine (Endocrinology, Diabetes and Metabolism)
Department: Medicine
Contact information
3400 Civic Center Blvd
Perelman Center for Advanced Medicine Suite 4 West
Smilow Center for Translational Research 11-142
Philadelphia, PA 19104
Perelman Center for Advanced Medicine Suite 4 West
Smilow Center for Translational Research 11-142
Philadelphia, PA 19104
Office: (215) 662-2300
Lab: (215) 898-3389
Lab: (215) 898-3389
Publications
Education:
BS (Neuroscience)
Vanderbilt University School of Arts and Science, 2007.
MD
Vanderbilt University School of Medicine , 2011.
MS (Clinical Investigation)
Vanderbilt University School of Medicine , 2016.
Permanent linkBS (Neuroscience)
Vanderbilt University School of Arts and Science, 2007.
MD
Vanderbilt University School of Medicine , 2011.
MS (Clinical Investigation)
Vanderbilt University School of Medicine , 2016.
Description of Clinical Expertise
type 2 diabetes prevention, atypical diabetes, metabolic disease, general endocrinology including thyroid disease, osteoporosis, PCOS, metabolic syndrome, hypogonadism, adrenal dysfunctionDescription of Research Expertise
type 2 diabetes prevention, rare genetic disorders of diabetes/ metabolism, long-term side effects of type 2 diabetes medications, atypical diabetes, cardiovascular related endocrine complicationsSelected Publications
McKenna, Amanda, Ana-Maria Chindris, Jessica Wilson: Hypoglycemia After Ingestion of Street "Valium" Containing Glyburide, Alcohol, and Cocaine. American Association of Clinical Endocrinology 2023 May 2023.Wilson JR, Garner EM, Mashayekhi M, Hubers SA, Ramirez Bustamante CE, Kerman SJ, Nian H, Shibao CA, Brown NJ: DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment. Hypertension 79(4), April 2022.
Eom YS, Wilson JR, Bernet VJ: Links between Thyroid Disorders and Glucose Homeostasis Diabetes Metab J 46(2), March 2022.
Rader DJ et al and CLLF580X2102 Study Team : LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults with Modest Hypertriglyceridemia J Clin Endocrinol Metabolism 107(1), Jan 2022.
Hu W, Jiang C, Kim M, Yang W, Zhu K, Guan D, LvW, Xiao Y, Wilson JR, Rader DJ, Pui CH, Relling MV, Lazar MA: Individual-specific functional epigenomics reveals genetic determinants of adverse metabolic effects of flucocorticoids. Cell Metab 33(8), Aug 2021.
Mona Mashayekhi, Jessica R Wilson, Scott Jafarian-Kerman, Hui Nian, Chang Yu, Megan M Shuey, James M Luther, Nancy J Brown: Association of a glucagon-like peptide-1 receptor gene variant with glucose response to a mixed meal. Diabetes Obes Metab 23(1): 281-286, Jan 2021.
Wilson, Jessica R, Megan M Shuey, Nancy J Brown, and Jessica K Devin: Response to Letter to the Editor: “Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin” Journal of the Endocrine Society. 4(3), March 2020 Notes: DOI: 10.1210/jendso/bvaa006 eCollection 2020 Mar.
Wilson, Jessica R, Scott Jafarian Kerman, Scott A. Hubers, Chang Yu, Hui Nian, Eric Grouzmann, Philippe Eugster, Dustin S. Mayfield, Nancy J. Brown: Dipeptidyl Peptidase 4 Inhibition Increases Postprandial Norepinephrine via Substance P (NK1R) during RAAS Inhibition. Journal of the Endocrine Society 3(10): 1784-98, Oct 2019.
Mona Mashayekhi, Jessica Wilson, Scott Jafarian-Kerman, Nancy Brown: The Effect of the GLP1R Variant rs6923761 on Post-Prandial Glucose Levels during Treatment with Sitagliptin. Endocrine Society Apr 2019 Notes: Oral presentation.
Hubers, Scott A, Jessica R Wilson, Chang Yu, Hui Nian, Eric Grouzmann, Cyndya A Shibao, Frederic T Billings, Scott Jafarian Kerman, and Nancy J Brown: DPP (Dipeptidyl Peptidase)-4 Inhibition Potentiates the Vasoconstrictor Response to NPY (Neuropeptide Y) in Humans During Renin-Angiotensin-Aldosterone System Inhibition. Hypertension 72(3): 712-19, Sept 2018.